Oral Anticoagulants: The Move Beyond Warfarin

J Neurosci Nurs. 2016 Jul-Aug;48(4):177. doi: 10.1097/JNN.0000000000000230.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Clinical Trials as Topic*
  • Drug Approval / methods
  • Factor Xa
  • Factor Xa Inhibitors / therapeutic use
  • Humans
  • Pyrazoles / therapeutic use
  • Pyridones / therapeutic use
  • Recombinant Proteins
  • Rivaroxaban / therapeutic use
  • Warfarin / administration & dosage*

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • PRT064445
  • Pyrazoles
  • Pyridones
  • Recombinant Proteins
  • apixaban
  • Warfarin
  • Rivaroxaban
  • Factor Xa